Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00658164
What this trial is testing

Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores

Who this might be right for
Nonalcoholic Fatty Liver Disease
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 150
Not applicableUnknownNCT01139632
What this trial is testing

The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseCoronary Artery Disease
Ziv Hospital 60
Not applicableStudy completedNCT01707914
What this trial is testing

Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Shaoguan University 44
Testing effectiveness (Phase 2)Study completedNCT04399538
What this trial is testing

Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis

Who this might be right for
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver Disease
Pfizer 75
Testing effectiveness (Phase 2)Study completedNCT01094158
What this trial is testing

Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisMetabolic Syndrome
Galmed Medical Reserch 60
Not applicableStudy completedNCT06121999
What this trial is testing

Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults

Who this might be right for
Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)Metabolic Associated-dysfunction Steatohepatitis (MASH)
Grand Valley State University 24
Testing effectiveness (Phase 2)Study completedNCT00501592
What this trial is testing

Study of INT-747 in Patients With Diabetes and Presumed NAFLD

Who this might be right for
Diabetes Mellitus, Type IIFatty Liver
Intercept Pharmaceuticals 64
Early research (Phase 1)Study completedNCT04546984
What this trial is testing

Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Sunshine Lake Pharma Co., Ltd. 66
Not applicableEnded earlyNCT03142867
What this trial is testing

The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Adults

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis
The Geneva Foundation 826
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Early research (Phase 1)Looking for participantsNCT07553663
What this trial is testing

Evaluating the Pharmacokinetics and Safety of Miricorilant

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics
Testing effectiveness (Phase 2)Study completedNCT02856555
What this trial is testing

Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences 127
Testing effectiveness (Phase 2)Ended earlyNCT03823703
What this trial is testing

Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Corcept Therapeutics 12
Not applicableStudy completedNCT04067440
What this trial is testing

Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool

Who this might be right for
ObesityDiabetes MellitusFatty Liver, Nonalcoholic+2 more
Universität des Saarlandes 30
Not applicableUnknownNCT04985188
What this trial is testing

Quantitative Ultrasound for Diagnosing Hepatic Steatosis in Nonalcoholic Fatty Liver Multicenter Study

Who this might be right for
Diagnoses Disease
Seoul National University Hospital 112
Testing effectiveness (Phase 2)Study completedNCT05011305
What this trial is testing

Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis

Who this might be right for
Nonalcoholic SteatohepatitisFibrosis
Zydus Therapeutics Inc. 189
Not applicableLooking for participantsNCT04371042
What this trial is testing

PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

Who this might be right for
NAFLD - Nonalcoholic Fatty Liver DiseaseDiabetesObesity+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 5,000
Not applicableEnded earlyNCT03534141
What this trial is testing

Mild Hypothermia and Acute Kidney Injury in Liver Transplantation

Who this might be right for
CirrhosisEnd Stage Liver DiseaseAcute Kidney Injury+7 more
University of California, San Francisco 175
Large-scale testing (Phase 3)Study completedNCT00063622
What this trial is testing

Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)

Who this might be right for
Liver Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 247
Testing effectiveness (Phase 2)Study completedNCT06465186
What this trial is testing

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisNAFLD+2 more
Merck Sharp & Dohme LLC 85
Next Page
15